Search

By Aliya Feroe In the weeks preceding Harvard Medical School’s (HMS) Revisit Weekend 2018, the LGBTQ+ and Allies at HMS (LAHMS) group made a clear goal to host a memorable weekend with the goal of 100% matriculation of the admitted self-identified LGBTQ+ students. Despite being a co-chair of LAHMS...

Boston, Mass. — The loss of tiny cells in the inner ear, known as “hair cells,” is a leading cause of hearing loss, a public health problem affecting at least one out of three people over the age of 65. Of the two varieties of hair cells, the “outer hair cells” act as micromotors that amplify...

Dr Heng's submission to Challenge titled "Automatic classification of clear cell renal tumors using deep learning: implications for diagnosis and prediction of metastasis" has been selected to receive an award.

Boston, Mass. — A team of surgeons at Massachusetts Eye and Ear found that, of 173 patients undergoing rhinoplasty, a common procedure performed in the facial plastic and reconstructive surgery field, only two refilled their opioid prescriptions after the procedure—with some patients not filling...

In two companion studies— “The Effect of Botulinum Toxin Augmentation on Strabismus Surgery for Large-Angle Infantile Esotropia” and “Long-term Surgical Outcomes for Large-angle Infantile Esotropia”—just published in the American Journal of Ophthalmology, Boston Children’s Hospital (BCH)...

Faculty from the Department of Otolaryngology at Harvard Medical School had an excellent representation in Atlanta, Georgia at the annual meeting of the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) earlier this month. There were more than 90 outstanding presentations by our...

New research findings from a study led by Kristina Simonyan, MD, PhD, Dr med, show the potential of a new oral drug for spasmodic dysphonia, a neurological disorder affecting the muscles of the larynx or voice box. The work was published last week in Scientific Reports. The study shows that sodium...

Harvard Medical School on Thursday slammed the Trump administration's reported plan to eliminate federal recognition of transgender, intersex, or gender non-binary individuals, calling the proposal “overly simplistic, medically inaccurate and antithetical to our values as healthcare providers.” Read...

On November 2, the 20th Annual Boston Angiogenesis Meeting (BAM) event attracted more than 100 faculty members and trainees from several Boston-area institutions to present, discuss, and network around their common interests in angiogenesis. Keynote speaker Nathan Lawson, PhD, a professor in the...